Eckert & Ziegler SE (LON: 0NZY)

Market Cap	855.35M
Revenue (ttm)	231.10M
Net Income (ttm)	24.45M
Shares Out	n/a
EPS (ttm)	1.17
PE Ratio	34.98
Forward PE	n/a
Dividend	4.33 (10.89%)
Ex-Dividend Date	Oct 3, 2024

Volume	1,500
Average Volume	1,938
Open	39.74
Previous Close	39.73
Day's Range	39.74 - 39.74
52-Week Range	32.74 - 59.00
Beta	1.33
RSI	57.65
Earnings Date	Mar 27, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2024
• Employees: 1,075
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NZY

Financial Performance

In 2023, Eckert & Ziegler SE's revenue was 246.09 million, an increase of 10.74% compared to the previous year's 222.23 million. Earnings were 26.30 million, a decrease of -10.17%.

Financial numbers in EUR